冠動脈の付随血流に対する血小板活性化の効果
1Division of Cardiology, Department of Internal Medicine, University of Minnesota Medical School, Minneapolis, Minn, USA.
Circulation
|October 7, 1998
まとめ
血小板活性化因子 (PAF) は,血管収縮を引き起こすことにより,冠動脈の付随血流を減少させます. この効果は,トランボキサンA2によって媒介され,これらの重要な血管を通る血流の調節におけるその役割を強調しています.
科学分野:
- 心血管生理学 心血管の生理学
- 血小板生物学 血小板生物学について
背景:
- 血小板産物であるトロンボキサンA2やセロトニンは,冠動脈側血管を収縮させる.
- 冠動脈の付随血流の減少における血小板活性化因子 (PAF) の役割は,以前は知られていなかった.
研究 の 目的:
- PAFによる血管内血小板活性化が冠動脈の付随血流を減少させることができるかどうかを調査する.
主な方法:
- 大人の犬では,LADエンボライゼーションによって冠動脈の付随血管の成長が誘発されました.
- 副次血流は,カヌル化された動脈からの逆行血流で測定されました.
- 血小板活性化因子 (PAF) は,左側主冠動脈に注射されました.
主要な成果:
- PAFの注射は,逆行血流の有意な減少を引き起こし,血管収縮を示唆しました.
- 血流の最大減量は40.3%で,15分以内に正常に戻った.
- トロンボキサンA2を阻害すると,PAFに対する血管圧縮反応が廃止され,血管拡張効果が明らかにされた.
結論:
- 血小板活性化因子 (PAF) は血管収縮を誘導し,冠動脈の付随血流を低下させます.
- PAFの冠動脈側血管に対する血管縮効果は,トロンボキサンA2.0に依存しています.
関連する概念動画
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...


